LEGN (Legend Biotech) FCF Yield % : -2.73 (As of Dec. 14, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Legend Biotech's Trailing 12-Month Free Cash Flow is $-176.2 Mil, and Market Cap is $6,442.8 Mil. Therefore, Legend Biotech's FCF Yield % for today is -2.73%.

The historical rank and industry rank for Legend Biotech's FCF Yield % or its related term are showing as below:

LEGN' s FCF Yield % Range Over the Past 10 Years
Min: -6.87 Med: -3.37 Max: -1.53
Current: -2.73

During the past 6 years, the highest FCF Yield % of Legend Biotech was -1.53%. The lowest was -6.87%. And the median was -3.37%.

LEGN's FCF Yield % is ranked better than
75.38% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs LEGN: -2.73

Legend Biotech's FCF Margin % for the quarter that ended in Sep. 2024 was -48.62%.

Legend Biotech FCF Yield % Historical Data

The historical data trend for Legend Biotech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech FCF Yield % Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-6.76

-3.39

-2.71

-3.80

Legend Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															-2.17	-3.75	0.36	-0.25	-3.49

Competitive Comparison of Legend Biotech's FCF Yield %

For the Biotechnology subindustry, Legend Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Legend Biotech's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Legend Biotech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Legend Biotech's FCF Yield % falls into.

Legend Biotech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Legend Biotech's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-415.998	/	10945.58487
	=	-3.80%

Legend Biotech's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-77.887	*	4	/	8939.56723
	=	-3.49%

Legend Biotech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Legend Biotech FCF Yield % Related Terms

Thank you for viewing the detailed overview of Legend Biotech's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

9LB:Germany

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.